Results 81 to 90 of about 20,433 (107)

Lymphatic Malformations With Activating KRAS Mutations Impair Lymphatic Valve Development Through Matrix Metalloproteinases. [PDF]

Arterioscler Thromb Vasc Biol
Mastrogiacomo DM, Price A, Fu Y, Banerjee R, Knauer LA, Li K, Yang Y, Davis GE, Dellinger MT, Scallan JP.   +9 more
europepmc   +1 more source

Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat? [PDF]

Int J Mol Sci
Zoń A, Bednarek IA.
europepmc   +1 more source

G0 or no-G0: phosphatase control of quiescence and cell cycle entry. [PDF]

Biochem Soc Trans
Robinson EA, Barr AR.
europepmc   +1 more source

Pathogenic mechanism of extracranial arteriovenous malformations: insights from clinical, pathological, and genetic analyses. [PDF]

Virchows Arch
Hirose K, Hori Y, Maruyama K, Motooka D, Hata K, Tahara S, Matsui T, Nojima S, Kohara M, Imanaka-Yoshida K, Toyosawa S, Morii E.   +11 more
europepmc   +1 more source

KRAS G12C inhibitors versus chemotherapy in second line and beyond in adults with advanced or metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation. [PDF]

Cochrane Database Syst Rev
Noordhof A, Asmara OD, de Jong K, Gijtenbeek RG, Huitema YM, van Vollenhoven FH, Venmans BJ, Hendriks L, van Geffen WH.   +8 more
europepmc   +1 more source

Crosstalk between circRNAs and the MAPK signaling pathway in cancer progression. [PDF]

Discov Oncol
Zahedi M, Maghrebi-Ghojogh E, Ahangari F, Zamani Sani M, Mafi A, Hushmandi K, Olianasab SA, Daneshi S, Alimohammadi M, Khoshnazar SM, Farahani N, Hashemi M, Taheriazam A.   +12 more
europepmc   +1 more source

The dynamic evolution of circulating tumor cells during glecirasib treatment predicts survival and resistance in gastrointestinal tumors with KRAS^G12C mutation. [PDF]

Hum Cell
Jiang L, Luo Y, Liang H, Feng X, Huang Y, Li Y, Wang Z, Xu T, Zou H, Li Z, Shen L, Chen Y, Wang W, Li J.   +13 more
europepmc   +1 more source

Expression of ras proto-oncogene related protein p21 in normal human skin and cutaneous tumours

Acta Histochemica, 1992
The cellular proto-oncogene, ras, is known to play an important role in the regulation of cell growth and proliferation in normal and malignant conditions. The present study was undertaken to immunohistochemically examine the expression of ras protooncogene product p21 in normal human skin and some cutaneous tumours.
E, Tanikawa, O, Mori, H, Hachisuka, Y, Sasai   +3 more
openaire   +4 more sources

K-ras proto-oncogene (KRAS): Evolutionary dissection on the indispensable predictive and prognostic cancer biomarker across 32 primates

Animal Gene, 2023
Lim Whye Kit Leonard
exaly  

Proton NMR studies of the GDP.Mg2+ complex of the Ha-ras oncogene product p21

Biochemical and Biophysical Research Communications, 1988
Ilme Schlichting, Paul Rosch, I Schlichting   +2 more
exaly